COMP <GO>
CHYM vs BRK-B // RETURN ON INVESTED CAPITAL (ROIC)
Chime Financial Inc. (NASDAQ) VS. Berkshire Hathaway Inc. (Class B) (NYSE) • 15-METRIC TALLY: CHYM 4
— BRK-B 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: BRK-B
LAST: $28.87 (+0.24%) • MKT CAP: $10.93B
roic
-35.00%
LAST: $541.96 (+0.30%) • MKT CAP: $1.20T
roic
11.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHYM VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHYM | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 11.47% | -46.47 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.42% | 2.09% | -2.51 | BRK-B | /fcf-yield <GO> |
| Operating Margin | -47.60% | 27.80% | -75.40 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | -46.20% | 22.30% | -68.50 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 30.70% | 3.93% | +26.77 | CHYM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | CHYM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.0 | 67.7 | -19.70 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.61 | +0.30 | CHYM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 24.3x | -2.34 | CHYM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.93B | $1.20T | -$1.18T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHYM REV | BRK-B REV | CHYM GROSS % | BRK-B GROSS % | CHYM FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.19B | $371.44B | 88.0% | — | -$45.6M | $25.04B |
| FY 2024 | $1.67B | $371.43B | 87.6% | — | -$11.2M | $11.62B |
| FY 2023 | $1.28B | $364.48B | — | — | -$214.1M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHYM // BETA 0.91
BRK-B // BETA 0.61